---
title: "Inspire Medical Systems, Inc. (INSP.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/INSP.US.md"
symbol: "INSP.US"
name: "Inspire Medical Systems, Inc."
industry: "医疗器械"
---

# Inspire Medical Systems, Inc. (INSP.US)

| Item | Detail |
|------|--------|
| Industry | 医疗器械 |
| Location | 美股市场 |
| Website | [www.inspiresleep.com](https://www.inspiresleep.com) |

## Company Profile

Inspire Medical Systems, Inc.是一家医疗科技公司，专注于为美国及国际上的阻塞性睡眠呼吸暂停（OSA）患者开发和商业化微创解决方案。该公司提供 Inspire 系统，这是一种神经刺激技术，为中度至重度 OSA 患者提供安全有效的治疗。它还开发了一种新型的闭环解决方案，持续监测患者的呼吸，并提供轻度舌下神经刺激以保持气道畅通。该公司成立于 2007 年，总部位于明尼苏达州的金谷

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:14.000Z

**Overall: A (0.20)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 1 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.60% |  |
| Net Profit YoY | 171.77% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.19 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.71B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 911.98M |  |


**Multi Score**: A

#### Profit Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 19.77% | A |
| Profit Margin | 15.95% | A |
| Gross Margin | 85.39% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.60% | B |
| Net Profit YoY | 171.77% | A |
| Total Assets YoY | 12.24% | B |
| Net Assets YoY | 13.26% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 627.13% | C |
| OCF YoY | 13.60% | B |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.06 | A |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 13.90% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Inspire Medical Systems, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "A",
      "indicators": [
        {
          "name": "ROE",
          "value": "19.77%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "15.95%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "85.39%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "13.60%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "171.77%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.24%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "13.26%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "627.13%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "13.60%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.06",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "13.90%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 启迪医疗 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 直觉外科 (US.ISRG) | A | B | C | A | B | B |
| 04 | 史赛克 (US.SYK) | A | B | C | C | B | B |
| 05 | 波士顿科学 (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 11.75 | 4/181 | 83.04 | 58.72 | 46.09 |
| PB | 2.19 | 57/181 | 6.64 | 5.51 | 3.50 |
| PS (TTM) | 1.87 | 51/181 | 5.45 | 4.16 | 2.73 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-18T05:00:00.000Z

Total Analysts: **17**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 24% |
| Overweight | 1 | 6% |
| Hold | 12 | 71% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 59.85 |
| Highest Target | 180.00 |
| Lowest Target | 81.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/INSP.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/INSP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/INSP.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
